ArrowMark Colorado Holdings’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-182,912
Closed -$6.44M 324
2017
Q1
$6.44M Buy
182,912
+32,387
+22% +$1.03M 0.09% 177
2016
Q4
$4.64M Buy
150,525
+37,443
+33% +$1.16M 0.07% 191
2016
Q3
$3.41M Buy
113,082
+23,547
+26% +$711K 0.06% 195
2016
Q2
$2.45M Buy
89,535
+21,946
+32% +$561K 0.05% 189
2016
Q1
$1.81M Buy
67,589
+3,228
+5% +$79K 0.04% 187
2015
Q4
$1.82M Buy
64,361
+10,983
+21% +$317K 0.05% 197
2015
Q3
$1.49M Buy
53,378
+9,845
+23% +$356K 0.04% 210
2015
Q2
$1.8M Sell
43,533
-27,250
-38% -$998K 0.04% 217
2015
Q1
$2.15M Buy
70,783
+14,004
+25% +$363K 0.06% 185
2014
Q4
$1.12M Buy
56,779
+41,924
+282% +$937K 0.03% 211
2014
Q3
$296K Buy
14,855
+4,837
+48% +$102K 0.01% 272
2014
Q2
$228K Sell
10,018
-3,792
-27% -$67.5K 0.01% 301
2014
Q1
$178K Sell
13,810
-1,778
-11% -$25.5K 0.01% 288
2013
Q4
$213K Buy
+15,588
New +$186K 0.01% 289

Other funds holding RGEN

ArrowMark Colorado Holdings's RGEN Position: Q2 2017 in Review

ArrowMark Colorado Holdings sold out of Repligen (RGEN) in Q2 2017, closing a stake of 182,912 shares — an estimated $6.44M sold.

ArrowMark Colorado Holdings first reported a position in RGEN in Q4 2013 and held it in 14 quarters. The position peaked at $6.44M in Q1 2017. 199 funds tracked by Wall St. Rank hold RGEN as of Q2 2017.

  • ArrowMark Colorado Holdings reported no remaining Repligen position as of Q2 2017 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 182,912 Repligen shares in Q2 2017, an estimated $6.44M.
  • ArrowMark Colorado Holdings first reported a position in Repligen in Q4 2013 and held it in 14 quarters.
  • ArrowMark Colorado Holdings's Repligen position peaked at $6.44M in Q1 2017.
  • 199 funds tracked by Wall St. Rank held Repligen as of Q2 2017.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2017, filed 14 Aug 2017.